GlassScriptPhysician profile
Dina Hansen
NPI 1326421280
$9,654.71
in general payments reported to CMS, 2019-2025
29 companies · $747 in 2025
The $747 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,694 · 2020: $3,239 · 2021: $1,055 · 2022: $736 · 2023: $581 · 2024: $603 · 2025: $747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,931.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,930.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $4,143.29 | 2019-2025 | Apligraf, Affinity, Puraply Wound Matrix |
| Integra Lifesciences Corporation | $2,100.33 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbott Laboratories | $801.06 | 2019-2025 | Freestyle Libre 3 |
| Smith+Nephew, INC. | $549.84 | 2019-2023 | Collagenase Santyl, Regranex |
| Stryker Corporation | $450.64 | 2019-2025 | Variax, Prostep |
| Treace Medical Concepts, INC. | $290.94 | 2022-2025 | |
| Boston Scientific Corporation | $218.74 | 2019-2021 | |
| Acera Surgical, INC. | $191.18 | 2020-2023 | Restrata Wound Matrix |
| Medtronic Vascular, INC. | $127.62 | 2020 | |
| Novo Nordisk INC | $124.46 | 2023 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.03 | 2024 | Jardiance |
| Djo, LLC | $82.44 | 2019 | |
| Ossio INC | $64.01 | 2021 | |
| Southern Edge Orthopaedics, INC. | $47.19 | 2024 | |
| Melinta Therapeutics, LLC | $44.24 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $43.01 | 2021-2022 | |
| Reprise Biomedical, INC. | $38.28 | 2024-2025 | Miro3d |
| Solventum Corporation | $27.95 | 2025 | Activ.A.C. |
| Ossdsign USA Incorporated | $23.94 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $21.90 | 2022 | |
| Triad Life Sciences INC. | $21.41 | 2022 | |
| Kci USA, INC. | $20.08 | 2022 | |
| Aroa Biosurgery Incorporated | $18.63 | 2022 | |
| Horizon Therapeutics Plc | $18.49 | 2021 | |
| Bioventus LLC | $15.83 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.79 | 2023 | Nuzyra |
| Exact Sciences Corporation | $14.35 | 2025 | Cologuard Collection Kit |
| Misonix INC | $12.85 | 2021 | |
| Zimmer Biomet Holdings, INC. | $12.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dina Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.